Skip to Content

Chorionic Gonadotropin (Human) Injection

Last Updated: April 20, 2018
Status: Resolved

Vincristine Sulfate Injection

Products Affected - Description
    • Vincasar injection, Teva, 1 mg/mL, 1 mL vial, 1 count, NDC 00703-4402-11
    • Vincasar injection, Teva, 1 mg/mL, 2 mL vial, 1 count, NDC 00703-4422-11
    • Vincristine injection, Pfizer, 1 mg/mL, 1 mL vial, 1 count, NDC 61703-0309-06
    • Vincristine injection, Pfizer, 1 mg/mL, 2 mL vial, 1 count, NDC 61703-0309-16
Reason for the Shortage
    • Pfizer has vincristine on shortage due to manufacturing delays.
    • Teva has Vincasar on shortage due to increased demand.

Estimated Resupply Dates

    • Pfizer has vincristine 1 mg/mL 1 mL and 2 mL vials available in limited supply.
    • Teva has Vincasar 1 mg/mL 1 mL and 2 mL vials on allocation. Check wholesaler for availability.

Updated

Updated April 20, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide